Track topics on Twitter Track topics that are important to you
BioRobotics was founded as a privately funded venture with the aim of providing quality solutions to automation and robotics in the field of molecular biology. The BioPick, the company’s first product, is used for the generation of genomic libraries. Capable of picking randomly grown colonies of yeast, Escherichia coli or phage into 96 or 384 well microtitre plates, the instrument runs unattended for up to 10 hours. In this time it will pick up to 10,000 clones and inoculate them into microplates, which are filled with media on-line. The BioGrid was added to the range in 1996. Compact sized, but with high throughput and capacity it is used to produce gridded arrays on membranes. This year BioRobotics has added the MicroGrid, an adaptation of the BioGrid, which allows the generation of custom microarrays of nucleic acids on solid substrates. A team of professional engineers and biologists work together to create optimised solutions to specific problems, and it is this multidisciplinary approach that has resulted in machines that are reliable, compact, easy to use and competitively priced. Distributor agreements are in place in Japan, Taiwan, China, Korea, New Zealand and Australia. There is a subsidiary company in Boston, MA, USA, and sales and marketing is direct from the UK to the rest of the world. BioRobotics has the long-term aim of continuing to grow through new product development funded from income. Ideas for further products are continually being evaluated.
BioRobotics BioPick BioGrid BioFill MicroGrid Automation Molecular Biology Genetics Genomics Instrumentation Colony Picking Gridding Membranes Filters Micro-array
Phone: 44 1223 873500
Fax: 44 1223 873589
HONG KONG, CHINA -- (Marketwired) -- 08/09/16 -- Hutchison China Meditech Limited (NASDAQ: HCM) Nasdaq: HCM Director's Share Dealing London: Tuesday, August 9, 2016: Hutchison China MediTech Limit...
HONG KONG, CHINA -- (Marketwired) -- 11/30/16 -- Hutchison China Meditech Limited (NASDAQ: HCM) (AIM: HCM) AIM/Nasdaq: HCM Total Voting Rights London: Wednesday, November 30, 2016: For informatio...
JERSEY, Channel Islands, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, announced today that the company and Stephen Unger, Chief Financia...
HONG KONG, CHINA -- (Marketwired) -- 11/30/16 -- Hutchison China Meditech Limited (NASDAQ: HCM) (AIM: HCM) AIM/Nasdaq: HCM Exercise of Share Options by a Person Discharging Managerial Responsibilit...
TORONTO, Sept. 19, 2016 (GLOBE NEWSWIRE) -- GeneNews Limited: Mr. Rory Riggs, a director of GeneNews Limited (“GeneNews”) (TSX:GEN), announces that, pursuant to a private placement which took...
HAMILTON, Bermuda, Aug. 24, 2016 (GLOBE NEWSWIRE) -- Golar LNG's 2nd Quarter 2016 results will be released before the NASDAQ opens on Wednesday August 31 2016. In connection with this a webcast prese...
JERSEY, Channel Islands, Oct. 14, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (“Quotient”) (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the completion of a private pla...
ABINGDON, OXON, United Kingdom, Oct. 12, 2016 (GLOBE NEWSWIRE) -- Immunocore Limited, a world-leading biotechnology company developing novel biological drugs to treat cancer, infectious diseases and ...
BioRobotics was founded as a privately funded venture with the aim of providing quality solutions to automation and robotics in the field of molecular biology. The BioPick, the company’s first produ...
We have published hundreds of BioRobotics Limited news stories on BioPortfolio along with dozens of BioRobotics Limited Clinical Trials and PubMed Articles about BioRobotics Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioRobotics Limited Companies in our database. You can also find out about relevant BioRobotics Limited Drugs and Medications on this site too.
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...